Trinity Biotech (TRIB) Invested Capital (2016 - 2025)
Trinity Biotech's Invested Capital history spans 11 years, with the latest figure at -$58.6 million for Q4 2025.
- On a quarterly basis, Invested Capital fell 161.18% to -$58.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$58.6 million, a 161.18% decrease, with the full-year FY2025 number at -$58.6 million, down 161.18% from a year prior.
- Invested Capital hit -$58.6 million in Q4 2025 for Trinity Biotech, down from $1.1 million in the prior quarter.
- Over the last five years, Invested Capital for TRIB hit a ceiling of $17.8 million in Q2 2022 and a floor of -$58.6 million in Q4 2025.
- Historically, Invested Capital has averaged -$3.1 million across 5 years, with a median of $810000.0 in 2021.
- The widest YoY moves for Invested Capital: up 3692.94% in 2022, down 4848.82% in 2022.
- Tracing TRIB's Invested Capital over 5 years: stood at $5.3 million in 2021, then tumbled by 138.6% to -$2.0 million in 2022, then skyrocketed by 889.06% to $16.2 million in 2023, then plummeted by 238.73% to -$22.4 million in 2024, then tumbled by 161.18% to -$58.6 million in 2025.
- Business Quant data shows Invested Capital for TRIB at -$58.6 million in Q4 2025, $1.1 million in Q2 2025, and -$22.4 million in Q4 2024.